Authors/Disclosures
|
Lindsey L. Lair, MD, FAAN
(Biohaven)
|
Dr. Lair has received personal compensation for serving as an employee of Biohaven. An immediate family member of Dr. Lair has received personal compensation for serving as an employee of PPD/Thermo Fisher Scientific. Dr. Lair has stock in Biohaven. An immediate family member of Dr. Lair has stock in PPD/Thermo Fisher Scientific. Dr. Lair has a non-compensated relationship as a Board Member with NY State Neurological Society that is relevant to AAN interests or activities. |
|
Alejandro Vargas, MD, MS, FAAN
(Rush University Medical Center)
|
Dr. Vargas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer U.S. LLC Pharmaceuticals. |
|
Roy L. Freeman, MD
(Beth Israel Deaconess Hosp)
|
Dr. Freeman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cutaneous Diagnostic Life Sciences. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. Dr. Freeman has received research support from Regeneron. |
|
Christopher H. Gibbons, MD, FAAN
(Beth Israel Deaconess Medical Center)
|
Dr. Gibbons has received personal compensation for serving as an employee of CND Life Sciences. Dr. Gibbons has or had stock in CND Life Sciences.Dr. Gibbons has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |